Array Technologies heads into its May 19 earnings with the most adversarial short positioning in months and options traders making their most defensive hedges of the past year.
The short interest story has been building steadily and is now impossible to ignore. SI climbed to 21.4% of the free float as of May 5 — up from 16.3% at the end of March, a rise of roughly five percentage points in six weeks. That is a 31% jump in raw share count over the past month. Short sellers moved in waves: the first step-up arrived in mid-April, taking SI from ~17% to just above 18%, then a second push in late April and early May carried it through 21%. At this level, more than one in five free-float shares is out on loan to a short. For a solar-hardware company navigating a difficult macro environment, that is a significant expression of bearish conviction.
The lending market is not yet flashing distress signals, but it is tightening. Availability has dropped to roughly 113% — down from the more comfortable readings of early April — reflecting increased demand for borrows as short interest has grown. Borrow costs remain contained at 0.57%, and the week-over-week move was actually lower, so there is no evidence of a forced squeeze in the making. But the directional trend is worth watching: as borrow demand rises with each new wave of short interest, availability will continue to tighten. The ORTEX short score has climbed to 70.98, ranking in just the 3rd percentile of the broader universe — meaning almost all stocks carry less short-side pressure.
Options positioning is the sharpest signal right now. The put/call ratio hit 0.99 on May 5 — its highest reading of the past 52 weeks and nearly two-and-a-half standard deviations above the 20-day mean of 0.50. That is a dramatic shift from mid-April, when the PCR was running around 0.34–0.37, signalling that options buyers were net bullish. The reversal is abrupt and concentrated in the last two weeks, suggesting investors are buying downside protection aggressively into a print that carries real uncertainty.
Analyst opinion has been mixed but leans cautious. Citigroup raised its target to $12 on April 21 while keeping its Buy rating — the lone bullish move in a sea of trims. JPMorgan cut to $9 from $11 earlier in April, and Barclays and Susquehanna both trimmed to $8 as tariff-related demand concerns spread across the solar sector. The consensus mean target of $9.86 implies roughly 20% upside from the current price of $8.18, but that figure is dragged up by the Citi outlier. The EV/EBITDA multiple has drifted up to 9.8x over the past month as the stock recovered — not cheap for a business facing margin headwinds from international growth and limited direct customer relationships. The bear case centres on demand softening, supply chain risk, and EPC-dependent revenue; bulls point to the recovery in revenue growth and rising EBITDA multiples. The analyst recommendation differential factor ranks in the 98th percentile, indicating the Street's gap between current ratings and implied price targets is unusually wide.
Institutional holders tell a more constructive story at the margin. BlackRock added nearly 1.2 million shares as of April 30, BNPP added 1.7 million, and Amundi built close to 2 million shares through February. Vanguard added 952,000 shares. Point72 entered as a new holder with a full 7.5 million-share position as of end-2025. These are passive and active managers building, not cutting — a counterweight to the short-seller narrative. Insider activity in March was largely equity-award-related, with the CEO, CFO and other executives receiving grants followed by modest tax-related sells; net insider activity over 90 days was a small positive in shares, not a directional signal.
The setup heading into May 19 earnings is a study in divergence: an accelerating short position and the most defensive options positioning of the year on one side, a stock that has recovered 11% over the past month and institutional managers still adding on the other. The most pointed question for the May 19 print is whether ARRY can demonstrate that the revenue recovery is durable enough to justify the multiple, or whether macro and tariff headwinds start showing up in the order book.
See the live data behind this article on ORTEX.
Open ARRY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
